Relationships between Skin Cancers and Blood Groups - Link between Non-melanomas and ABO/Rh Factors

  • Cihan, Yasemin Benderli (Department of Radiation Oncology, Kayseri Education and Research Hospital) ;
  • Baykan, Halit (Department of Plastic Surgery, Kayseri Education and Research Hospital) ;
  • Kavuncuoglu, Erhan (Department of Computer Technologies, Cumhuriyet University Gemerek Vocation School) ;
  • Mutlu, Hasan (Medical Oncology, Kayseri Acıbadem Hospital) ;
  • Kucukoglu, Mehmet Burhan (Erciyes University Medicine School) ;
  • Ozyurt, Kemal (Department of Dermatology, Kayseri Education and Research Hospital) ;
  • Oguz, Arzu (Department of Medical Oncology, Kayseri Education and Research Hospital)
  • Published : 2013.07.30


Background: This investigation focused on possible relationships between skin cancers and ABO/Rh blood groups. Materials and Methods: Between January 2005 and December 2012, medical data of 255 patients with skin cancers who were admitted to Kayseri Training and Research Hospital, Radiation Oncology and Plastic Surgery Outpatient Clinics were retrospectively analyzed. Blood groups of these patients were recorded. The control group consisted of 25701 healthy volunteers who were admitted to Kayseri Training and Research Hospital, Blood Donation Center between January 2010 and December 2011. The distribution of the blood groups of the patients with skin cancers was compared to the distribution of ABO/Rh blood groups of healthy controls. The association of the histopathological subtypes of skin cancer with the blood groups was also investigated. Results: Of the patients, 50.2% had A type, 26.3% had O type, 16.1% had B type, and 7.5% had AB blood group with a positive Rh (+) in 77.3%. Of the controls, 44.3% had A type, 31.5% had 0 type, 16.1% had B type, and 8.1% had AB blood group with a positive Rh (+) in 87.8%. There was a statistically significant difference in the distribution of blood groups and Rh factors (A Rh (-) and 0 Rh positive) between the patients and controls. A total of 36.8% and 20.4% of the patients with basal cell carcinoma (BCC) had A Rh (+) and B Rh (+), respectively, while 39.2% and 27.6% of the controls had A Rh (+) and B Rh (+), respectively. A significant relationship was observed between the patients with BCC and controls in terms of A Rh (-) (p=0.001). Conclusion: Our study results demonstrated that there is a significant relationship between non-melanoma skin cancer and ABO/Rh factors.


ABO blood group;skin cancer;Rh factor;basal cell carcinoma;squamous cell carcinoma


  1. Adamian RT (2005). Blood-type and rhesus distribution in Armenian women with endometrial carcinoma. Vopr Onkol, 51, 575-6.
  2. Aird I, Bentall HH, Roberts JA (1953). A relationship between cancer of stomach and the ABO blood groups. Brit Med J, 1, 799-801.
  3. Alavi S, Ashraf H, Rashidi A, et al (2006). Distribution of ABO blood groups in childhood acute leukemia. Pediatr Hematol Oncol, 23, 611-7.
  4. Armstrong BK, Kricker A (1995). Skin cancer. Dermatol Clin, 13, 583-94.
  5. Ben Q, Wang K, Yuan Y, et al (2011). Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer, 128, 1179-86.
  6. Cerny T, Fey MF, Oppliger R, et al (2006). Prevalence of the rhesus-negative phenotype in caucasian patients with small-cell lung cancer (SCLC). Int J Cancer, 52, 504-6.
  7. Coon JS, Weinstein RS (1986). Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas. Hum Pathol, 17, 1089-106.
  8. Edgren G, Hjalgrim H, Rostgaard K, et al (2010). Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol, 172, 1280-5
  9. El Hajj II, Hashash JG, Baz EM, et al (2007). ABO blood group and gastric cancer: rekindling an old fire? South Med J, 100, 726-7.
  10. Ghazizadeh M, Kagawa S, Kurokawa K (1983). A, B, O (H) blood group antigen distribution in normal skin and squamous cell carcinoma of the penis. Urol Res, 11, 267-9.
  11. Greer JB, Yazer MH, Raval JS, et al (2010). Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol, 16, 5588-91.
  12. Guleria K, Singh HP, Kaur H (2005). ABO blood groups in gastrointestinal tract (GIT) and breast carcinoma patients. Anthropologist, 7, 189-92.
  13. Henderson J, Seagrott V, Goldacre M (1993). Ovarian cancer and ABO blood groups. J Epidemiol Community Health, 47, 287-9.
  14. Hosoi E (2008). Biological and clinical aspects of ABO blood group system. J Med Invest, 55, 174-82.
  15. Ichikawa D, Handa K, Hakomori S (1998). Histo-blood group A/B antigen deletion/reduction vs. continuous expression in human tumor cells as correlated with their malignancy. Int J Cancer, 76, 284-9.<284::AID-IJC17>3.0.CO;2-C
  16. Iodice S, Maisonneuve P, Botteri E, et al (2010). ABO blood group and cancer. Eur J Cancer, 46, 3345-50.
  17. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA: Cancer J Clin, 61, 69-90.
  18. Jordon D, Jagirdar J, Kaneko M (1989). Blood group antigens, lewisx and lewisy in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma. Am J Pathol, 135, 931-7.
  19. Jordan GH, Lynch DF (1983). Relationship of blood group to testicular carcinoma. Urology, 22, 265-7.
  20. Karakousis CP, Evlogimenos E, Suh O (1986). Blood groups and malignant melanoma. J Surg Oncol, 33, 24-6.
  21. Landsteiner K (1900). Zur kenntnis der antifermentativen, lytischen and agglutinierenden wirkungen des blutserums und der lymphe. Zentralbl Bakteriol, 27, 357-62.
  22. Mittal VP (1970). Blood groups and cancer of the cervix uteri. J Obstet Gynaecol India, 20, 240-2.
  23. Mehrazin M (2006). ABO blood group frequency and brain tumors. Asian Pac Cancer Prev, 7, 582-4.
  24. Moldvay J, Scheid P, Wild P, et al (2000). Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res, 6, 1125-34.
  25. Nakagoe T, Nanashima A, Sawai T, et al (2000). Expression of blood group antigens A, B, and H in carcinoma tissue correlates with a poor prognosis for colorectal cancer patients. J Cancer Res Clin Oncol, 126, 375-82.
  26. Nozoe T, Ezaki T, Baba H, et al (2004). Correlation of ABO blood group with clinicopathologic characteristics of patients with esophageal squamous cell carcinoma. Dis Esophagus, 17, 1469.
  27. Otley C (2006). Non-Hodgkin lymphoma and skin cancer: a dangerous combination. Australas J Dermatol, 47, 231-6.
  28. Pinkston JA, Cole P (1996). ABO blood groups and salivary gland tumors (Alabama, United States). Cancer Causes Control, 7, 572-4.
  29. Pyd M, Rzewnicki I, Suwayach U (1995). ABO blood groups in patients with laryngeal and hypopharyngeal cancer. Otolaryngol Pol, 49, 396-401.
  30. Rolfe KJ, Nieto JJ, Reid WM et al (2002). Is there a link between vulval cancer and blood group? Eur J Gynaecol Oncol, 23, 111-2.
  31. Slater G, Itzkowitz S, Azar S, et al (1993) Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer. Dis Colon Rectum, 36, 5-7.
  32. Su M, Lu SM, Tian DP, et al (2001). Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China. World J Gastroenterol, 7, 657-61.
  33. Tursen U, Tiftik EN, Unal S, et al (2005). Relationship between ABO blood groups and skin cancers. Dermatol Online J, 11, 44.
  34. Vadivelu MK, Damodaran S, Solomon J, et al (2004). Distribution of ABO blood groups in acute leukaemias and lymphomas. Ann Hematol, 83, 584-7.
  35. Vincenzo G, Marta G, Alessia G, et al (2011). ABO blood group and risk of cutaneous malignant melanoma. Eur J Cancer Prev, 20, 121-2.
  36. Xie J, Qureshi AA, Li Y, Han J (2010). ABO blood group and incidence of skin cancer. PLoS One, 5, 11972.

Cited by

  1. Significance of ABO-Rh Blood Groups in Response and Prognosis in Breast Cancer Patients Treated with Radiotherapy and Chemotherapy vol.15, pp.9, 2014,
  2. Changing Trends of Types of Skin Cancer in Iran vol.16, pp.12, 2015,
  3. Negative HER2/neu Amplification Using Immunohistochemistry and Chromogenic in Situ Hybridization Techniques in Skin Melanoma Cases vol.16, pp.2, 2015,
  4. Roles of White Blood Cells and Subtypes as Inflammatory Markers in Skin Cancer vol.16, pp.6, 2015,
  5. Association between ABO Genotype and Risk of Hepatocellular Carcinoma in Koreans vol.16, pp.7, 2015,
  6. The Effect of Educational Intervention Based on Health Belief Model and Social Support on Promoting Skin Cancer Preventive Behaviors in a Sample of Iranian Farmers pp.1543-0154, 2018,